{
    "paper_id": "9b75fe020ec7b8a5ee0399a61135cbdfe18a50f8",
    "metadata": {
        "title": "Twenty Years of Active Bacterial Core Surveillance Technical Appendix Technical Appendix Table. Key uses and findings of Active Bacterial Core surveillance data for vaccine development, evaluation, and policy formulation* Pathogen Vaccines Key uses and findings Streptococcus pneumoniae PCV7 and PCV13 Selection of serotypes included in PCV7and PCV13 Informed ACIP recommendations for children <5 y of age (1,2) Tracking postlicensure declines in cases (3) Documented effectiveness of PCV7 (4) Monitoring incidence of non-vaccine serotypes (5) Accelerated regulatory approval of PCV13 (6) Informed ACIP recommendations for PCV13 use in immunocompromised adults and children (7,8) Neisseria meningitidis Conjugate vaccines Serogroup B vaccines",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Informed ACIP recommendations for children 11-18 y of age (9) (10) (11) Informed ACIP recommendations for booster dose (12) Documented vaccine effectiveness (13) Informed ACIP infant meningococcal recommendations (14) Evaluated potential effect on serogroup B disease in United States (15) Haemophilus influenzae",
            "cite_spans": [
                {
                    "start": 58,
                    "end": 61,
                    "text": "(9)",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 62,
                    "end": 66,
                    "text": "(10)",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 67,
                    "end": 71,
                    "text": "(11)",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 119,
                    "end": 123,
                    "text": "(12)",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 157,
                    "end": 161,
                    "text": "(13)",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 213,
                    "end": 217,
                    "text": "(14)",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 285,
                    "end": 289,
                    "text": "(15)",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Tracking postlicensure declines in Hib disease (16) Tracking shift toward non-Hib disease (16 Determining population groups to target (23) *ACIP, Advisory Committee on Immunization Practices; Hib, H. influenzae type b vaccine; PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine.",
            "cite_spans": [
                {
                    "start": 47,
                    "end": 51,
                    "text": "(16)",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 134,
                    "end": 138,
                    "text": "(23)",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "Hib vaccine"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Preventing pneumococcal disease among infants and young children",
            "authors": [],
            "year": 2000,
            "venue": "Centers for Disease Control and Prevention",
            "volume": "49",
            "issn": "RR09",
            "pages": "1--35",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP)",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Nuorti",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Whitney",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "MMWR Recomm Rep",
            "volume": "59",
            "issn": "11",
            "pages": "1--18",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Pilishvili",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "201",
            "issn": "",
            "pages": "32--41",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Whitney",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Lancet",
            "volume": "368",
            "issn": "",
            "pages": "1495--502",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Moore",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Whitney",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "10.1086/524661. PubMed 6. FDA. Vaccines, Blood and Biologics: Prevnar 13",
            "volume": "46",
            "issn": "",
            "pages": "183--188",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)",
            "authors": [],
            "year": 2012,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "61",
            "issn": "",
            "pages": "816--825",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)",
            "authors": [],
            "year": 2013,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "62",
            "issn": "",
            "pages": "521--525",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine",
            "authors": [],
            "year": 2007,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "56",
            "issn": "",
            "pages": "794--799",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Risk of meningococcal infection in college students",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "JAMA",
            "volume": "281",
            "issn": "",
            "pages": "1906--1916",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Invasive meningococcal disease in adolescents and young adults",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "JAMA",
            "volume": "286",
            "issn": "",
            "pages": "694--703",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Updated recommendations for use of meningococcal conjugate vaccines-Advisory Committee on Immunization Practices (ACIP)",
            "authors": [],
            "year": 2010,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "60",
            "issn": "",
            "pages": "72--78",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Early estimate of the effectiveness of quadrivalent meningococcal conjugate vaccine",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Macneil",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Pediatr Infect Dis J",
            "volume": "30",
            "issn": "",
            "pages": "451--456",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Infant meningococcal vaccination: Advisory Committee on Immunization Practices (ACIP) recommendations and rationale",
            "authors": [],
            "year": 2013,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "62",
            "issn": "",
            "pages": "52--56",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Cohn",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Infect Dis",
            "volume": "50",
            "issn": "",
            "pages": "184--91",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Current epidemiology and trends in invasive Haemophilus influenzae disease-United States",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Macneil",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "Clin Infect Dis",
            "volume": "53",
            "issn": "",
            "pages": "1230--1236",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Haemophilus influenzae type b disease and vaccine booster dose deferral, United States",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Briere",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Pediatrics",
            "volume": "130",
            "issn": "",
            "pages": "414--434",
            "other_ids": {
                "DOI": [
                    "10.1542/peds.2012-0266"
                ]
            }
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Continued shortage of Haemophilus influenzae Type B (Hib) conjugate vaccines and potential implications for Hib surveillance-United States",
            "authors": [],
            "year": 2008,
            "venue": "MMWR Morb Mortal Wkly Rep",
            "volume": "57",
            "issn": "",
            "pages": "1252--1257",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Jackson",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Emerg Infect Dis",
            "volume": "18",
            "issn": "",
            "pages": "13--20",
            "other_ids": {
                "DOI": [
                    "10.3201/eid1801.110336"
                ]
            }
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Mcneil",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Clin Infect Dis",
            "volume": "41",
            "issn": "",
            "pages": "1114--1136",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "E"
                    ],
                    "last": "O&apos;loughlin",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Clin Infect Dis",
            "volume": "45",
            "issn": "",
            "pages": "853--62",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early-and late-onset invasive disease in young-infants",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Madhi",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Vaccine",
            "volume": "31",
            "issn": "4",
            "pages": "52--59",
            "other_ids": {
                "DOI": [
                    "10.1016/j.vaccine.2013.02.029"
                ]
            }
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Lucero",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Vaccine",
            "volume": "27",
            "issn": "",
            "pages": "5061--5069",
            "other_ids": {}
        }
    },
    "ref_entries": {},
    "back_matter": []
}